Hrt Financial LP Werewolf Therapeutics, Inc. Transaction History
Hrt Financial LP
- $17 Billion
- Q2 2024
A detailed history of Hrt Financial LP transactions in Werewolf Therapeutics, Inc. stock. As of the latest transaction made, Hrt Financial LP holds 197,377 shares of HOWL stock, worth $418,439. This represents 0.0% of its overall portfolio holdings.
Number of Shares
197,377
Previous 37,628
424.55%
Holding current value
$418,439
Previous $243,000
97.94%
% of portfolio
0.0%
Previous 0.0%
Shares
2 transactions
Others Institutions Holding HOWL
# of Institutions
72Shares Held
32.2MCall Options Held
53.8KPut Options Held
1.3K-
Ra Capital Management, L.P. Boston, MA6.14MShares$13 Million0.23% of portfolio
-
Mpm Asset Management LLC Cambridge, MA4.28MShares$9.08 Million5.74% of portfolio
-
Pfm Health Sciences, LP San Francisco, CA3.24MShares$6.87 Million0.41% of portfolio
-
Bio Impact Capital LLC Cambridge, MA2.39MShares$5.06 Million0.94% of portfolio
-
Bank Of America Corp Charlotte, NC2.15MShares$4.55 Million0.0% of portfolio
About Werewolf Therapeutics, Inc.
- Ticker HOWL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,529,400
- Market Cap $62.6M
- Description
- Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional ...